Avalo Therapeutics, Inc.

AVTX·NasdaqCM·Healthcare
Compare
7.07−0.18 (−2.48%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close7.25
Open7.47
Day range6.797.59
52-week range6.5324.27
Off day high−6.81%
Off 52-week high−70.87%
Volume1.38M
Avg. volume (3M)1.56M
Market cap379.16M
EPS (TTM)-4.31
Forward P/E-2.54
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.75
Shares outstanding53.63M
Short interest22.34% of float
Earnings dateAug 6, 2026 (est.)
Analyst target36.60
Profit margin0.00%

Against its peers

Compare in full ›
AVTX AVLN AUTL AVCT.L ACTI.ST XLO
Market cap 379.16M 1.22B 367.30M 247.70M 101.49M 57.31M
P/E (TTM) — — — — — —
Forward P/E -2.5 -10.6 -2.2 -21.0 — -15.0
Price/book 0.8 3.1 4.9 70.7 2.7 0.8
Dividend yield — — — — — —
1-year change −55.93% −9.09% +2.17% −20.03% −34.67% −23.93%
Today −2.48% +2.46% −2.47% −1.57% +4.62% +0.35%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All AVTX news ›

From the 4Search news index, newest first.

In the news

16mentions in 30 days
11with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance